JNE Partners LLP - Q3 2020 holdings

$115 Million is the total value of JNE Partners LLP's 6 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 50.0% .

 Value Shares↓ Weighting
UHAL  AMERCO$25,569,000
+17.8%
71,8260.0%22.32%
-18.1%
NG SellNOVAGOLD RES INC$25,391,000
-8.7%
2,135,519
-29.5%
22.16%
-36.6%
SCHW NewSCHWAB CHARLES CORP$20,325,000561,000
+100.0%
17.74%
HST NewHOST HOTELS & RESORTS INC$19,446,0001,802,200
+100.0%
16.97%
CMCSA  COMCAST CORP NEWcl a$16,557,000
+18.7%
357,9020.0%14.45%
-17.5%
COTY SellCOTY INC$7,276,000
-54.9%
2,694,732
-25.3%
6.35%
-68.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings